May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Involvement of cyclooxygenase–2 in rat models of anterior ocular inflammation.
Author Affiliations & Notes
  • M. Azuma
    Research Laboratories, Senju Pharmaceutical Co Ltd, Kobe, Japan
  • T. Oka
    Research Laboratories, Senju Pharmaceutical Co Ltd, Kobe, Japan
  • T.R. Shearer
    Department of Integrative Biosciences, Oregon Health & Science University, Portland, OR
  • Footnotes
    Commercial Relationships  M. Azuma, Senju Pharmaceutical E; T. Oka, Senju Pharmaceutical E; T.R. Shearer, Senju Pharmaceutical C.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 569. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Azuma, T. Oka, T.R. Shearer; Involvement of cyclooxygenase–2 in rat models of anterior ocular inflammation. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):569.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:To determine which isoform of cyclooxygenase (COX), constitutive COX–1 or inducible COX–2, is involved in two rat models of anterior ocular inflammation. Methods:To induce conjunctivitis, carrageenan or bacterial lipopolysaccharide (LPS) was injected into rat conjunctivae. Vascular permeability in inflamed conjunctivae was measured by uptake of systemic Evans blue dye. Changes in mRNA or protein for COX–1 and COX–2 in conjunctivae were detected by RT–PCR or by immunoblotting, respectively. To elucidate involvement of COX–2 in conjunctivitis, COX–2 inhibitor was topically administrated. Results:The dye content of conjunctivae was significantly increased 4 hours after injection of carrageenan or LPS. In the carrageenan–injected model, mRNA for COX–2 was significantly increased by 2 hours and gradually increased until 24 hours. In the LPS–injected model, mRNA for COX–2 was significantly increased 1 hour after injection, peaked at 2 hours, and decreased at 4 hours. COX–1 mRNA did not show major changes until 24 hours after injection of carrageenan or LPS. COX–2 protein increased 4 hours (carrageenan) or 2 hours (LPS) after injection. Topical administration of COX–2 inhibitor lowered dye–leakage into conjunctiva 4 hours after injection of carrageenan or LPS. Conclusions:These results suggested that the mechanism for anterior ocular inflammation may due to up–regulation of COX–2.

Keywords: conjunctivitis • inflammation • enzymes/enzyme inhibitors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×